Search clinical trials for: Lamisil® 250 mg Tablets

Total 4430 results

Labopharm Inc.

Completed

A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers

Healthy

United Kingdom
Mylan Pharmaceuticals Inc

Completed

Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Healthy

United States
University of Southern California

Unknown

Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle

Ovulation; Failure or Lack of
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Fasting

Healthy

United States
Pharmaceutical Research Unit, Jordan

Completed

Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions

Healthy

Jordan
Teva Pharmaceuticals USA

Completed

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Luye Pharma Group Ltd.
Shandong Luye Pharmaceutical Co., Ltd.

Completed

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder

China
UCB Biopharma SRL

Withdrawn

A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil

Epilepsy | Healthy Participants
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Solid Tumor | Advanced Solid Tumor

Spain, United States, Netherlands, United Kingdom
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

Healthy

United States
Bausch Health Americas, Inc.

Completed

Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis

Liver Cirrhosis

United States, Russian Federation
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

Chronic Myeloid Leukemia | Gastrointestinal Stromal Tumor

Korea, Republic of
Qanatpharma Canada LTD

Completed

Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets

Healthy Volunteer

Canada
HighTide Biopharma Pty Ltd

Completed

A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia

Hypercholesterolemia

Australia
GlaxoSmithKline

Completed

A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

HIV Infections | Infection, Human Immunodeficiency Virus

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Japan
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets, Non-Fasting

Healthy

United States
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions

Fed

India
GL Pharm Tech Corporation

Unknown

The Pharmacokinetics of GLA5PR Tablet According to the Renal Function

Neuropathic Pain

Korea, Republic of
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

Healthy

United States
GlaxoSmithKline

Completed

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

Gastroparesis

United States, Australia, Belgium, United Kingdom, Canada, Sweden
Eleonora Seelig

Completed

Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals (Gluco-Feed)

Glucocorticoid Effect

Switzerland
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed Conditions

Healthy Subjects

Canada
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions

Healthy Subjects

Canada
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition

Fasting

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions

Healthy

India
The Netherlands Cancer Institute

Completed

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir

Cancer

Netherlands
Ardea Biosciences, Inc.

Completed

Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

Healthy

United States
Novartis Pharmaceuticals

Recruiting

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Fascioliasis

Vietnam, Egypt, Colombia, Peru
Teva Pharmaceuticals USA

Completed

Famciclovir 500 mg Tablets Under Fasting Conditions

Healthy

United States, Canada
Sandoz

Completed

Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.

Mild and Moderate Iron-deficiency Anaemia

Russian Federation
Mutual Pharmaceutical Company, Inc.

Completed

Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

Healthy

Canada
Mylan Pharmaceuticals Inc

Completed

Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg

Healthy

United States
Future University in Egypt

Completed

Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition

Healthy Subjects

Egypt
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

Small Cell Lung Carcinoma | Small-cell Lung Cancer

United States
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Healthy

United States
Vertex Pharmaceuticals Incorporated
Cystic Fibrosis Foundation

Completed

Safety Study of Ivacaftor in Subjects With Cystic Fibrosis

Cystic Fibrosis

United States, Canada, Germany
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions

Healthy

United States
Pila Pharma

Completed

A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2

Diabetes Mellitus, Type 2

Denmark
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Tablets Under Fed Conditions

Healthy

Canada
Merck Sharp & Dohme LLC

Completed

Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)

Migraine
Joint Stock Company "Farmak"

Completed

Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
GlaxoSmithKline

Terminated

A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers

Community-acquired Infection

United States

3

Subscribe